CHOSANCT07600333
CPAP vs High-Flow Nasal Cannula for Treating Sleep Apnea in Children
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Eligibility criteria expanded, about 11 words
- Start date changed from estimate of Jun 1, 2026 to May 27, 2026
- Secondary endpoints: details revised at 13 of 15 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (15)
Show 10 moreShow less
Arms and interventions
Participants assigned to this arm will receive Continuous Positive Airway Pressure (CPAP) therapy for the treatment of obstructive sleep apnea. CPAP delivers pressurized air through a mask worn during sleep to keep the airway open. Participants will use CPAP at home each night during sleep for a three-month intervention period, with device settings optimized based on standard clinical care.
Participants assigned to this arm will receive High-Flow Nasal Cannula (HFNC) therapy for the treatment of obstructive sleep apnea. HFNC delivers warmed, humidified air at high flow rates through soft nasal prongs to support airway patency during sleep. Participants will use HFNC at home each night during sleep for a three-month intervention period, with flow settings optimized based on standard clinical care.
Devices: High Flow Nasal Cannula, Continuous Positive Airway Pressure
Sites
1 site in 1 country
- The Hospital for Sick ChildrenToronto, Ontario, Canada